» Articles » PMID: 17110663

Outcome of Acute Vertebrobasilar Occlusions Treated with Intra-arterial Fibrinolysis in 180 Patients

Overview
Specialty Neurology
Date 2006 Nov 18
PMID 17110663
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: To evaluate predictors of recanalization and a favorable neurologic outcome in patients with acute vertebrobasilar occlusion (VBO) treated with local intra-arterial fibrinolysis (LIF).

Methods: The multicentric data of 180 patients with acute VBO treated with LIF were retrospectively evaluated. The modified Rankin scale (mRS) was used to evaluate the neurologic status before LIF and at the time of discharge. Patient's sex, age, etiology of VBO, recanalization, symptom duration before LIF, and pretreatment mRS were correlated with posttreatment mRS. Multiple logistic regression analysis was used to identify independent variables for recanalization and neurologic outcome.

Results: The overall mortality was 43%. Complete recanalization was achieved in 99 (55%) patients and a partial recanalization in 35 (19%) patients, respectively. Recanalization was significantly associated with a favorable outcome (P < .001). The success of recanalization was negatively correlated with the volume of the thrombus (P < .001). No correlation was found between site and etiology of VBO and recanalization. Neurologic outcome correlated strongly with the pretreatment mRS (P < .001) and also with age (P < .02). Coma lasting less than 4.5 hours led to a positive trend toward a better outcome after univariate testing (P < .001).

Conclusions: Success of recanalization and neurologic status before treatment predict neurologic outcome in patients with VBO. Thrombus volume has an adverse effect on the recanalization success.

Citing Articles

Patterns of Care in Patients with Basilar Artery Occlusion (BAO): A Population-Based Study.

Farooqui M, Ikram A, Suriya S, Qeadan F, Bzdyra P, Quadri S Life (Basel). 2023; 13(3).

PMID: 36983984 PMC: 10053211. DOI: 10.3390/life13030829.


Deep-Learning-Based Thrombus Localization and Segmentation in Patients with Posterior Circulation Stroke.

Zoetmulder R, Bruggeman A, Isgum I, Gavves E, Majoie C, Beenen L Diagnostics (Basel). 2022; 12(6).

PMID: 35741209 PMC: 9222185. DOI: 10.3390/diagnostics12061400.


Invasive Management of Vertebrobasilar Artery Stenosis and Occlusion: A Meta-Analysis on Efficacy and Safety Endpoints.

Nso N, Nassar M, Trimingham M, Mbome Y, Ngonge A, Badejoko S Cureus. 2022; 14(5):e24751.

PMID: 35686282 PMC: 9170364. DOI: 10.7759/cureus.24751.


Therapy for acute basilar artery occlusion: a systematic review and meta-analysis.

Sheng K, Tong M F1000Res. 2019; 8:165.

PMID: 31016013 PMC: 6456838. DOI: 10.12688/f1000research.18042.1.


Acute basilar thrombosis: Recanalization following intravenous thrombolysis is dependent on thrombus length.

Janssen H, Bruckmann H, Killer M, Heck S, Buchholz G, Lutz J PLoS One. 2018; 13(2):e0193051.

PMID: 29466399 PMC: 5821367. DOI: 10.1371/journal.pone.0193051.


References
1.
Mayer T, Hamann G, Schulte-Altedorneburg G, Bruckmann H . Treatment of vertebrobasilar occlusion by using a coronary waterjet thrombectomy device: a pilot study. AJNR Am J Neuroradiol. 2005; 26(6):1389-94. PMC: 8149074. View

2.
Eckert B, Koch C, Thomalla G, Kucinski T, Grzyska U, Roether J . Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke.... Stroke. 2005; 36(6):1160-5. DOI: 10.1161/01.STR.0000165918.80812.1e. View

3.
Wallace R, Furlan A, Moliterno D, STEVENS G, Masaryk T, Perl 2nd J . Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor. AJNR Am J Neuroradiol. 1997; 18(7):1257-60. PMC: 8338011. View

4.
Zeumer H, Hacke W, Ringelstein E . Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol. 1983; 4(3):401-4. PMC: 8334942. View

5.
. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985; 312(14):932-6. DOI: 10.1056/NEJM198504043121437. View